• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

观察性研究的标准和指南:质量取决于观察者的看法。

Standards and guidelines for observational studies: quality is in the eye of the beholder.

机构信息

Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, 130 DeSoto Street, Pittsburgh, PA 15261, USA.

Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, 130 DeSoto Street, Pittsburgh, PA 15261, USA.

出版信息

J Clin Epidemiol. 2016 Mar;71:3-10. doi: 10.1016/j.jclinepi.2015.10.014. Epub 2015 Nov 5.

DOI:10.1016/j.jclinepi.2015.10.014
PMID:26548541
Abstract

OBJECTIVES

Patient care decisions demand high-quality research. To assist those decisions, numerous observational studies are being performed. Are the standards and guidelines to assess observational studies consistent and actionable? What policy considerations should be considered to ensure decision makers can determine if an observational study is of high-quality and valid to inform treatment decisions?

STUDY DESIGN AND SETTING

Based on a literature review and input from six experts, we compared and contrasted nine standards/guidelines using 23 methodological elements involved in observational studies (e.g., study protocol, data analysis, and so forth).

RESULTS

Fourteen elements (61%) were addressed by at least seven standards/guidelines; 12 of these elements disagreed in the approach. Nine elements (39%) were addressed by six or fewer standards/guidelines. Ten elements (43%) were not actionable in at least one standard/guideline that addressed the element.

CONCLUSION

The lack of observational study standard/guideline agreement may contribute to variation in study conduct; disparities in what is considered credible research; and ultimately, what evidence is adopted. A common set of agreed on standards/guidelines for conducting observational studies will benefit funders, researchers, journal editors, and decision makers.

摘要

目的

患者护理决策需要高质量的研究。为了辅助这些决策,正在进行大量的观察性研究。评估观察性研究的标准和指南是否一致且可行?为了确保决策者能够确定观察性研究的质量和有效性,以告知治疗决策,应考虑哪些政策考虑因素?

研究设计和设置

基于文献回顾和六位专家的意见,我们使用涉及观察性研究的 23 个方法学要素(例如研究方案、数据分析等)比较和对比了九项标准/指南。

结果

至少有七项标准/指南涵盖了 14 个要素(61%);其中 12 个要素的处理方法不一致。有 9 个要素(39%)被六个或更少的标准/指南涵盖。在至少一个涵盖该要素的标准/指南中,有 10 个要素(43%)不可操作。

结论

缺乏观察性研究标准/指南的一致性可能导致研究实施的差异;对可信研究的看法存在差异;最终影响所采用的证据。一套针对观察性研究的通用标准/指南将使资助者、研究人员、期刊编辑和决策者受益。

相似文献

1
Standards and guidelines for observational studies: quality is in the eye of the beholder.观察性研究的标准和指南:质量取决于观察者的看法。
J Clin Epidemiol. 2016 Mar;71:3-10. doi: 10.1016/j.jclinepi.2015.10.014. Epub 2015 Nov 5.
2
Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.基于证据的医学、系统评价以及介入性疼痛管理指南:第6部分。观察性研究的系统评价与荟萃分析
Pain Physician. 2009 Sep-Oct;12(5):819-50.
3
It is important to note that RWD will never replace the more traditional and more robust RCT data; however, the emerging trend is to incorporate data that are more generalizable. Introduction.需要注意的是,真实世界数据(RWD)永远无法取代更为传统且更为可靠的随机对照试验(RCT)数据;然而,新出现的趋势是纳入更具普遍性的数据。引言。
J Manag Care Pharm. 2011 Nov-Dec;17(9 Suppl A):S03-4.
4
A questionnaire to assess the relevance and credibility of observational studies to inform health care decision making: an ISPOR-AMCP-NPC Good Practice Task Force report.评估观察性研究对医疗保健决策的相关性和可信度的问卷:ISPOR-AMCP-NPC 良好实践工作组报告。
Value Health. 2014 Mar;17(2):143-56. doi: 10.1016/j.jval.2013.12.011.
5
Informing Healthcare Decisions with Observational Research Assessing Causal Effect. An Official American Thoracic Society Research Statement.运用观察性研究评估因果效应来为医疗保健决策提供信息。美国胸科学会官方研究声明。
Am J Respir Crit Care Med. 2021 Jan 1;203(1):14-23. doi: 10.1164/rccm.202010-3943ST.
6
The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.ISPOR 成本效益研究质量改进良好实践工作组报告。
Value Health. 2009 Nov-Dec;12(8):1086-99. doi: 10.1111/j.1524-4733.2009.00605.x. Epub 2009 Sep 10.
7
Untapped Potential of Observational Research to Inform Clinical Decision Making: American Society of Clinical Oncology Research Statement.观察性研究在为临床决策提供信息方面的未开发潜力:美国临床肿瘤学会研究声明。
J Clin Oncol. 2017 Jun 1;35(16):1845-1854. doi: 10.1200/JCO.2017.72.6414. Epub 2017 Mar 30.
8
Prospective observational studies to assess comparative effectiveness: the ISPOR good research practices task force report.前瞻性观察性研究评估比较有效性:ISPOR 良好研究实践工作组报告。
Value Health. 2012 Mar-Apr;15(2):217-30. doi: 10.1016/j.jval.2011.12.010.
9
Assessing the reporting of categorised quantitative variables in observational epidemiological studies.评估观察性流行病学研究中分类定量变量的报告情况。
BMC Health Serv Res. 2017 Mar 14;17(1):201. doi: 10.1186/s12913-017-2137-z.
10
Guidelines for reporting evaluations based on observational methodology.基于观察性方法的评估报告指南。
Psicothema. 2015;27(3):283-9. doi: 10.7334/psicothema2014.276.

引用本文的文献

1
Application of Real-World Evidence to Support FDA Regulatory Decision Making.应用真实世界证据支持美国食品药品监督管理局的监管决策
AAPS J. 2025 May 28;27(4):98. doi: 10.1208/s12248-025-01082-1.
2
Oncoral Follow-Up for Outpatients Treated with Oral Anticancer Drugs Assessed by Relative Dose Intensity.通过相对剂量强度评估口服抗癌药物治疗门诊患者的昂科瑞随访。
Pharmaceuticals (Basel). 2025 Apr 13;18(4):565. doi: 10.3390/ph18040565.
3
Integrating randomized controlled trials and non-randomized studies of interventions to assess the effect of rare events: a Bayesian re-analysis of two meta-analyses.
整合干预措施的随机对照试验和非随机研究,以评估罕见事件的效果:对两项荟萃分析的贝叶斯重新分析。
BMC Med Res Methodol. 2024 Sep 27;24(1):219. doi: 10.1186/s12874-024-02347-7.
4
What, Where, and How to Collect Real-World Data and Generate Real-World Evidence to Support Drug Reimbursement Decision-Making in Asia: A reflection Into the Past and A Way Forward.亚洲如何收集真实世界数据和产生真实世界证据以支持药物报销决策:回顾过去与展望未来
Int J Health Policy Manag. 2023;12:6858. doi: 10.34172/ijhpm.2023.6858. Epub 2023 Mar 6.
5
Observational studies must be reformed before the next pandemic.在下一次大流行之前,观察性研究必须进行改革。
Nat Med. 2023 Aug;29(8):1903-1905. doi: 10.1038/s41591-023-02375-8.
6
Influenza and Pneumococcal Vaccination and the Risk of COVID-19: A Systematic Review and Meta-Analysis.流感和肺炎球菌疫苗接种与新冠病毒病风险:一项系统评价和荟萃分析
Diagnostics (Basel). 2022 Dec 7;12(12):3086. doi: 10.3390/diagnostics12123086.
7
[Extensions of guidelines for reporting types of study in medicine].[医学研究报告类型指南的扩展内容]
Rev Med Inst Mex Seguro Soc. 2022 Oct 25;60(6):675-682.
8
RWD-Cockpit: Application for Quality Assessment of Real-world Data.真实世界数据驾驶舱:真实世界数据质量评估应用程序。
JMIR Form Res. 2022 Oct 18;6(10):e29920. doi: 10.2196/29920.
9
A systematic review of methodological approaches for evaluating real-world effectiveness of COVID-19 vaccines: Advising resource-constrained settings.系统评价评估 COVID-19 疫苗真实世界有效性的方法学研究:为资源有限环境提供建议。
PLoS One. 2022 Jan 11;17(1):e0261930. doi: 10.1371/journal.pone.0261930. eCollection 2022.
10
How well can we assess the validity of non-randomised studies of medications? A systematic review of assessment tools.我们能多好地评估药物非随机研究的有效性?评估工具的系统评价。
BMJ Open. 2021 Mar 24;11(3):e043961. doi: 10.1136/bmjopen-2020-043961.